Table 5

Change in distribution of HbA1c in PCTs making marginal investments versus those not

Good control, n (%)Moderate control, n (%)Poor control, n (%)
PCTs that invested N=23
 2007/2008 (before)≤7.5 (61%)7.6–10 (27%)>10 (12%)
 2010/2011 (after)≤7 (48%)7.1–9 (34%)>9 (18%)
PCTs that did not invest N=12
 2007/2008 (before)≤7.5 (60%)7.6–10 (28%)>10 (12%)
 2010/2011 (after)≤7 (46%)7.1–9 (36%)>9 (18%)
  • HbA1c, glycated haemoglobin; PCT, primary care trust.